Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by StockDoc60on Oct 01, 2020 11:58am
66 Views
Post# 31649043

RE:RE:RE:AVCR-TSXV MOMENTUM IS COVID RELATED

RE:RE:RE:AVCR-TSXV MOMENTUM IS COVID RELATED

Hey ,Thor !

Tell us something concrete about AVCR and how they will quickly get contracts and Equipment for this venture when they had revenue of 8000cad last quarter and a net loss of 200,000cad. 

We know  Abbott is a solid company so there is no need to quote their share price !! simply tell us how you  see AVCR ( the strikeout darling for 5 years)  hitting a home run anytime soon .
 
Not sure on this but since Abbott has the devices to test ,They might well have the software to disseminate results  as well .

Off course no where has there been a news release connecting AVCR to Abbott !!

Maybe Hodo said it best with regards to the investors who jumped on the bandwagon in the last week or so .

THEY HAVE SOMETHING THAT MIGHT BE USEFUL IN THIS PANDEMIC AND PEOPLE ARE GAMBLING THAT THEY MIGHT GET A CONTRACT AND THIS STOCK WILL SOAR


 

Bullboard Posts